Medtronic Alters Covidien Acquistion Financing
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will use $16 billion in external financing to acquire Covidien rather than cash from foreign subsidiaries following a recent rule change by the Treasury Department targeting corporate inversions.